Clinical trial
Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for…
NCT00430027 · University of Colorado, Denver, Other · Terminated
Key facts
| NCT number | NCT00430027 |
|---|---|
| Title | Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma |
| Official title | Pilot Feasibility Trial of Preoperative Capecitabine, Oxaliplatin, Cetuximab and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | Bristol-Myers Squibb Industry Sanofi |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Esophageal Adenocarcinoma |
| Intervention type | Drug |
| Interventions | Capecitabine, Oxaliplatin, Cetuximab |
| Enrollment | 8 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Feb 1, 2007 |
| Last update posted | Dec 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: